key: cord-0891191-umxgkk34 authors: Shi, Qiao; Zhao, Kailiang; Yu, Jia; Jiang, Fang; Feng, Jiarui; Zhao, Kaiping; Zhang, Xiaoyi; Chen, Xiaoyan; Hu, Peng; Hong, Yupu; Li, Man; Liu, Fang; Chen, Chen; Wang, Weixing title: Clinical characteristics of 101 COVID-19 nonsurvivors in Wuhan, China: a retrospective study date: 2020-03-06 journal: nan DOI: 10.1101/2020.03.04.20031039 sha: cd1ce5594ba5c6c3dbbb2da3c42a7ac3cbd62ffa doc_id: 891191 cord_uid: umxgkk34 Background The outbreak of COVID-19 has aroused global concerns. Few studies focused on characteristics of COVID-19 nonsurvivors. Objective In this study, we aimed to describe the clinical characteristics of 101 nonsurvivors with COVID-19 and analyze risk factors associated with the rapid disease progress to death after admission. Design Retrospective study using electronic medical records. Participants 101 hospitalized patients with confirmed COVID-19 died in Renmin Hospital of Wuhan University before February 15, 2020, were included in this study. Main measures We obtained epidemiological, demographic, clinical, laboratory, and outcome data from electronic medical records. Univariate logistic regression analyses were performed to evaluate risk factors associated with rapid disease progress to death after admission. Key results Among included nonsurvivors, the median age was 71.0 years (IQR, 59.0-80.0), 60 (59.4%) were men. Eighty-two (79.2%) had one or more comorbidities including hypertension (58.4%), diabetes (21.8%) etc. Respiratory failure (99.0%), acute cardiac injury (52.5%), sepsis (40.6%) and acute kidney injury (22.8%) were most common complications. Patients died within 3 days of admission were more likely to develop sepsis compared with those survived 3 days of admission. Higher heart rate and respiration rate, increased white blood cell count and neutrophil count, elevated myoglobin level and depressed oxygen saturation on admission were associated with rapid disease progress to death within 3 days of admission. The AUCs for white blood cell count and neutrophil count were 0.71 (95% CI, 0.60-0.80) and 0.70 (95% CI, 0.59-0.79), respectively. Conclusions Older patients with underlying comorbidities suffering COVID-19 were at increased risks of death. Respiratory failure, acute cardiac injury and acute kidney injury played crucial roles in the death of COVID-19 patients. Of importance, early development of sepsis, increased white blood cell count and neutrophil count on admission were associated with the rapid disease progress to death. (22.77%) and 18 (17.82%) patients, respectively. Chest computed tomographic scans of non-survivors showed vast and fused ground-glass shadows. Compared to patients who survived 3 days, no statistical difference was noticed on lung severity score (11.91 vs 12.07) in patients who died within 3 days. Furthermore, significant elevated laboratory indicators including hypersensitive troponin (1.98 vs 0.2ng/ml), blood urea nitrogen (15.20 vs 10.08mmol/l), neutrophil count (11.23 vs 6.48×109/L), procalcitonin (2.26 vs 0.58ng/ml) and lactic acid (3.80 vs 2.62 mmol/l) etc. were noted in patients who died with 3 days while PaO2 (54.75 vs 67.45mmHg), CD3% (51.57 vs 60.43%) and CD8% (16.42 vs 23.42%) were significantly depressed. Older patients (>70 years) with comorbidities had a steeply increased risk of death when they suffered COVID-19. Besides respiratory failure, acute cardiac and kidney damage or failure, secondary to COVID-19, played a crucial role in causing death of patients. Since December 2019, the outbreak of corona virus disease-19 (COVID-19) which swept across China and emerged in many other countries have caused global concerns [1] . As of March 4, 2020, a total of 80420 COVID-19 cases in China have been confirmed and over 2900 lost their life. In the early stages of this COVID-19, respiratory infection symptoms occurred, with some patients rapidly developed acute respiratory distress syndrome (ARDS), acute respiratory failure and even death. Respiratory Syndrome (MERS), the concealed onset, similar or stronger contagion and lower mortality could be defined as the clinical features of the disease [2] [3] [4] . However, many patients suffered a death attack in the early stages of the outbreak in Wuhan City, China. Previous studies concentrated to show the epidemiological findings, clinical characteristics, and clinical outcome of patient with COVID-19 involved in mild and severe cases [5] [6] . But those infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are vulnerable to suffer severe attack or death, the causes that lead to the occurrence of rapid death are necessary to be addressed further. Information regarding clinical features of death caused by COVID-19 has not been reported yet. We aimed to describe the demographic, clinical, laboratory, radiological characteristics and outcomes of non-surviving hospitalized patients confirmed with SARS-CoV-2 infection, and to analyze the possible risk factors that lead to death of SARS-CoV-2 infected patients. In this study, we investigated the characteristics of non-surviving patients with confirmed SARS-CoV-2 infection admitted to Renmin Hospital of Wuhan University (including Shouyi campus and Eastern campus) before February 15, 2020 . We hope that this study will provide some important information regarding to death of SARS-CoV-2 infected patients. Compared with patients who survived 3 days, patients who died within 3 days All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 6, 2020. . https://doi.org/10.1101/2020.03.04.20031039 doi: medRxiv preprint exhibited significantly higher respiration rate (25 vs 20) and heart rate (97 vs 84) at presentation. There were no significant differences of self-report symptoms between two groups including fever, dyspnea, cough, fatigue etc. (Table 1) There were quite a lot differences of laboratory parameters between patients who died within 3 days of admission and those survived 3 days. Those died within 3 days of admission had significantly higher white blood cell count (12.36 ×10 9 vs 7.72×10 9 /L), neutrophil count (11.23×10 9 vs 6.48×10 9 /L) and lower eosinophils count (0.009 ×10 9 vs 0.028×10 9 /L). Compared with patients who survived 3 days of admission, patients died within 3 days presented with significantly higher percentage of neutrophils (88.86% vs 81.95%) but significantly lower percentages of lymphocytes (7.18% vs 10.94%), monocytes (3.8% vs 6.56%) and eosinophils (0.06% vs 0.34%). For other biochemical indexes, procalcitonin (2.26 vs 0.58 ng/ml), hsTnI (1.98 vs 0.2 ng/ml), Creatine kinase-MB (6.14 vs 2.78 ng/ml), myoglobin (437.7 vs 216.8 ug/L) and blood urea nitrogen (15.2 vs 10.08 mmol/L) were over normal range and significantly higher in patients died within 3 days of admission. (Table 3) Blood gas analyses showed patients died within 3 days presented with significantly lower oxygen saturation (80.58% vs 88.37%), higher lactate level (3.80 vs 2.62 mmol/L) and lower pH value (7.40 vs 7.42) compared with those survived 3 days. Although patients died within 3 days of admission had higher PaCO2 (38.97 vs 35.44 mmHg) and lower PaO2 (54.75 vs 67.45 mmHg), but there were no significant differences between two groups ( Table 4) . Cellular and humoral immunity analysis also revealed several differences between patients died within and over 3 days including percentage of CD3 + cells and CD8 + cells, concentrations of IgE antibody and C3 complement. Although only percentage of CD3 + cells in patients died within 3 days was below normal range, the percentage of CD3 + cells (51.57% vs 60.43%) and CD8 + cells (16.42% vs 23.42%) were significantly lower in patients died within 3 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 6, 2020. Table 6 . Among all treatments, except for noninvasive ventilation, no significant difference was noted between two groups. This report, to our knowledge, is the largest case series to analyze died patients with COVID-19 in hospital. As of February 15, 2020, 101 patients died because of All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 6, 2020. Although previous study reported the mortality of patients with COVID-19 is 1.4% [12] , some special population including the aged and individuals with underlying comorbidities may be vulnerable to SARS-CoV-2 infection. In our cohort, the median age of non-survivor was 71 years, 81.19% of them combined with one or more underlying medical conditions including hypertension, cardiovascular disease, diabetes, chronic pulmonary disease, cerebrovascular disease, chronic kidney disease and malignancy. This study suggested that patients aged over 70 years with chronic medical conditions were more likely to suffer a severe attack and death. Common symptoms at onset of COVID-19 were fever, dry cough, myalgia, fatigue etc. [5, 13] . In our cohort, we observed that, besides fever and cough, dyspnea (58.42%) presented early in most non-survivors with confirmed COVID-19, similar finding has also been observed in critically ill patients reported by Yang etc. [14] . In these non-survivors, featured complications during hospitalization including ARDS and respiratory failure, acute cardiac injury (ACI), AKI, acute liver injury (ALI) and abnormal coagulation. In terms of SARS, severe respiratory failure was the leading cause of mortality, with little other organ failure [15] . It is surprised that we observed 52.48% and 22.77% non-survivors suffered heart failure and AKI, respectively. Angiotensin-converting enzyme 2 (ACE2), a crucial SARS-CoV-2 receptor, distributed widely in heart, kidney and intestine etc. [16] [17] [18] . Whether SARS-CoV-2 attack heart and kidney or other vital organs directly need to be confirmed further. The most common laboratory abnormalities observed in this study were elevated white blood cell count, neutrophil count, C-reactive protein, high sensitivity troponin, blood urea nitrogen and decreased lymphocytes percentage etc. (Table 3, All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Compared with those died after 3 days of admission, non-survivors died within 3 days had numerous different findings including depressed percentages of lymphocyte, CD3 + and CD8 + cells, and elevated white blood cell count, high sensitivity troponin and urea nitrogen etc. These evidences suggest that SARS-CoV-2 infection may be associated with cellular immune deficiency, acute myocardial injury and kidney injury etc. These results also support the described organ failure above. In addition, the characteristic chest CT imaging of these non-survivors were evaluated by previous described method [19] . The CT features demonstrated extensive infection and severe damage, regarded as "white lung", in five lobes, but no significant difference was found between the two groups. These characteristics combined with above repented organ failure, laboratory abnormalities suggested that early organ dysfunction or failure were responsible for rapid progression of disease and death of the patients. Up to now, no antiviral treatment has been recommended for coronavirus treatment except supportive care and organ support [5, 20] . In current clinical practice, arbidol was used as an antiviral treatment for SARS-CoV-2 infected patients, but the curative effect remains unclear. Other antiviral medications including remdesivir and lopinavir etc. are still being verified in clinical trials. Furthermore, use of intravenous immunoglobulin is recommended to enhance the ability of anti-infection for severely ill patients and steroids are recommended for patients with ARDS, for as short duration of treatment as possible [21] . In this study, 96.04% patients received antiviral therapy, 98.02% received antibacterial therapy. Use of glucocorticoid mainly depended on the severity of inflammatory response. In the early outbreak of COVID-19, all the non-survivors received oxygen inhalation therapy including high flow oxygen inhalation (77.23%), but quite a low proportion of patients received machine ventilation partly due to limited medical resources against the steeply increasing number of patients. Several limitations existed in this study. Firstly, nearly two thirds of these All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 6, 2020. . https://doi.org/10.1101/2020.03.04.20031039 doi: medRxiv preprint non-survivors had no chest CT data in our medical system (because most of these patients were transferred from other hospitals without electronic version of imaging data) and evaluation of these imaging features partly depended on the experience of clinicians and radiologists. Secondly, incomplete medical information of some non-survivors may lead to the occurrence of bias. Thirdly, patients died within a short time after admission is unfavorable to track risk factors for this poor outcome. Finally, in the early outbreak of COVID-19, relatively inadequate medical resources may affect the observation of the natural course of disease. The findings of our study suggested that older patients (>70 years) with comorbidities are at higher risks for poor outcomes. Besides respiratory failure, acute heart injury and kidney injury, secondary to COVID-19, played a crucial role in causing death of patients. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All authors declared no conflict of interest. Patient consent: waived. Transparency: The manuscript's supervisors affirm that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned have been explained. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. A novel coronavirus outbreak of global health concern Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected Acute respiratory failure in Clinical characteristics of 2019 novel coronavirus infection in China A novel coronavirus from patients with pneumonia in China Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Short-term outcome of critically ill patients with severe acute respiratory syndrome The ACE2/angiotensin-(1-7)/ MAS axis of the renin-angiotensin system: focus on angiotensin ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding CT imaging features of 2019 novel coronavirus (2019-nCoV)